SynTech Research highlights an important regulatory development regarding ethanol as an active substance under the EU Biocidal Products Regulation (BPR).
On 24 February 2026, the Biocidal Products Committee (BPC) of the European Chemicals Agency adopted opinions supporting the approval of ethanol for several key product types. This milestone represents a significant step in the ongoing regulatory process that could affect a wide range of disinfectant and hygiene products marketed in the European Union.
What are the products types covered by the BPC opinion supporting ethanol approval?
The BPC adopted opinions supporting the approval of ethanol as an active substance for use in the following product types:
- PT 1: Human hygiene products
- PT 2: Disinfectants and algaecides not intended for direct contact with humans or animals
- PT 4: Disinfectants used in food and feed areas
These product types include many widely used disinfectant and hygiene solutions across healthcare, industry, and food processing environments.
The BPC opinion has now been forwarded to the European Commission. The Commission will prepare a draft Implementing Regulation that will propose either approval or non-approval of ethanol under the BPR framework.
What would formal approval mean for companies?
If ethanol is formally approved as an active substance under the BPR, biocidal products containing ethanol will need to be authorized in accordance with the regulation.
This means companies will need to obtain:
- National authorization, granted by individual EU Member States, or
- Union authorization, allowing a product to be marketed across the EU
Authorization requires the preparation and submission of comprehensive regulatory dossiers demonstrating product safety, efficacy, and compliance with BPR requirements.
For organizations currently relying on transitional measures, this development signals the need to prepare for full regulatory compliance.
How can SynTech Research support your BPR strategy?
SynTech Research supports companies in aligning their biocidal product portfolios with BPR requirements and managing the transition toward full regulatory compliance.
Our services include:
- Strategic planning to transition from transitional measures to full BPR compliance
- Data gap analysis to assess regulatory data requirements
- Preparation and submission of product authorization dossiers for national and Union authorization
- Regulatory monitoring and ongoing compliance support throughout the authorization process
Our goal is to ensure a smooth and timely regulatory transition while minimizing business disruption and safeguarding product continuity across the EU market.
Early portfolio assessment is recommended
Companies with ethanol-containing biocidal products are encouraged to conduct an early assessment of their portfolios. This allows organizations to understand potential regulatory implications and prepare for timely compliance once the Commission reaches its decision.
Early preparation can help avoid delays in authorization and ensure continued market access across the European Union.
Contact SynTech Research
If you are unsure how this development may affect your portfolio or regulatory strategy, SynTech Research’s regulatory experts are available to help.